Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Baituxiao Botanical Formula: Product, Label and Evidence ProfileRepresentative category illustration – no product packaging is shown.Baituxiao Botanical Formula: Product, Label and Evidence Profile
Baituxiao is marketed as a botanical supplement for pet wellness, comfort, vitality and normal immune function. It is not an FDA-approved cancer drug, and the manufacturer's own disclaimer…
Read more
Lomustine (CCNU) in Veterinary Oncology: Delayed-Toxicity Safety Profile
Lomustine, also called CCNU, is an oral nitrosourea chemotherapy drug used by veterinary oncologists for selected cancers. Use in dogs and cats is generally extra-label and requires a…
Read more
Multimodal Pain Management in Canine Cancer Care
Multimodal pain management combines approaches that act at different points in the pain pathway and addresses both the tumor and its functional consequences. A plan may include prescriptions,…
Read more
Appetite Support: Find and Treat the Reason a Dog Is Not Eating
Reduced appetite can result from nausea, pain, fever, constipation, oral disease, swallowing difficulty, medication effects, tumor location, stress, or metabolic illness. Appetite support starts by investigating and treating…
Read more
Omega-3 Fatty Acid Support: Product, Dose, and Evidence Questions
Omega-3 products are nutritional supplements, not cancer treatments. EPA and DHA content, total calories, oxidation control, formulation, and quality vary widely, and evidence from one condition or diet…
Read moreMetronomic Chemotherapy: Goal, Evidence, and Handling Boundary
Metronomic therapy uses regularly scheduled cytotoxic medication in selected plans; it remains prescription hazardous-drug treatment and is not simply gentle chemotherapy.
Read moreHome Handling of Oral Chemotherapy and Patient Waste
Families need drug-specific written instructions for receiving, storing, administering, cleaning, laundering, and disposing of chemotherapy and contaminated patient waste.
Read moreGabapentin as an Adjunct in Cancer Pain Plans
Gabapentin may be one component of multimodal pain or anxiety support, but effectiveness varies and sedation, weakness, kidney function, and compounded products need review.
Read more
Chemotherapy-Associated Diarrhea: Support Without Automatic Antibiotics
Diarrhea after cancer treatment needs severity, hydration, blood-count, infection, diet, medicine, and obstruction review rather than a one-size-fits-all remedy.
Read moreConstipation and Difficult Defecation in Cancer Care
Difficult defecation can reflect dehydration, pain, immobility, medication effects, pelvic or intestinal obstruction, neurologic disease, or inadequate intake and needs cause-based care.
Read more
Oral Mucositis and Mouth-Pain Support During Cancer Treatment
Painful oral inflammation or ulceration can interfere with eating, drinking, grooming, and medication and requires examination of treatment effects, infection, tumor, dental disease, and trauma.
Read moreNutrition Screening From Cancer Diagnosis Through Follow-Up
Routine nutrition screening identifies intake, weight, muscle, diet, gastrointestinal, and feeding barriers early enough to act before severe loss develops.
Read more